NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹294 Cr | ₹225 Cr | ₹137 Cr | ₹64 Cr | ₹130 Cr |
What is the latest Capital Work in Progress ratio of NATCO PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹294 Cr |
| Mar2025 | ₹225 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹130 Cr |
How is Capital Work in Progress of NATCO PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹294 Cr | 30.30 | |
| Mar2025 | ₹225 Cr | 64.17 | |
| Mar2024 | ₹137 Cr | 113.53 | |
| Mar2023 | ₹64 Cr | -50.35 | |
| Mar2022 | ₹130 Cr | - | |
Compare Capital Work in Progress of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,492.0 Cr | 0.2% | -4% | -4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.2% |
-4% |
-4.9% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses